BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 19711267)

  • 1. Prostate cancer screening in Greece: current facts.
    Stamatiou K; Lardas M; Kostakos E; Koutsonasios V; Lepidas D
    Urol J; 2009; 6(3):157-61. PubMed ID: 19711267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic evaluation of prostate cancer screening with prostate-specific antigen.
    Imamura T; Yasunaga H
    Int J Urol; 2008 Apr; 15(4):285-8. PubMed ID: 18380812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study).
    Hoffman RM; Couper MP; Zikmund-Fisher BJ; Levin CA; McNaughton-Collins M; Helitzer DL; VanHoewyk J; Barry MJ
    Arch Intern Med; 2009 Sep; 169(17):1611-8. PubMed ID: 19786681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elderly and prostate cancer screening.
    Stamatiou KN
    Urol J; 2011; 8(2):83-7. PubMed ID: 21656465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer screening: clinical applications and challenges.
    Brawley OW
    Urol Oncol; 2004; 22(4):353-7. PubMed ID: 15283896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate specific antigen best practice statement: 2009 update.
    Greene KL; Albertsen PC; Babaian RJ; Carter HB; Gann PH; Han M; Kuban DA; Sartor AO; Stanford JL; Zietman A; Carroll P
    J Urol; 2009 Nov; 182(5):2232-41. PubMed ID: 19781717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer screening: the continuing controversy.
    Wilbur J
    Am Fam Physician; 2008 Dec; 78(12):1377-84. PubMed ID: 19119557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A model of prostate-specific antigen screening outcomes for low- to high-risk men: information to support informed choices.
    Howard K; Barratt A; Mann GJ; Patel MI
    Arch Intern Med; 2009 Sep; 169(17):1603-10. PubMed ID: 19786680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate-specific antigen-based screening for prostate cancer: evidence, controversies and future perspectives.
    Ito K
    Int J Urol; 2009 May; 16(5):458-64. PubMed ID: 19341365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The patient's dilemma: prostate cancer treatment choices.
    Patel HR; Mirsadraee S; Emberton M
    J Urol; 2003 Mar; 169(3):828-33. PubMed ID: 12576794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rural residence and prostate cancer screening with prostate-specific antigen.
    Stamatiou K; Skolarikos A
    Rural Remote Health; 2009; 9(2):1227. PubMed ID: 19594290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of cancer screening services in Greece and associated social factors: results from the nation-wide Hellas Health I survey.
    Dimitrakaki C; Boulamatsis D; Mariolis A; Kontodimopoulos N; Niakas D; Tountas Y
    Eur J Cancer Prev; 2009 Jun; 18(3):248-57. PubMed ID: 19491613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What influences men's decision to have a prostate-specific antigen test? A qualitative study.
    Rai T; Clements A; Bukach C; Shine B; Austoker J; Watson E
    Fam Pract; 2007 Sep; 24(4):365-71. PubMed ID: 17644829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Internet patient decision support: a randomized controlled trial comparing alternative approaches for men considering prostate cancer screening.
    Frosch DL; Bhatnagar V; Tally S; Hamori CJ; Kaplan RM
    Arch Intern Med; 2008 Feb; 168(4):363-9. PubMed ID: 18299490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health information styles among participants in a prostate cancer screening informed decision-making intervention.
    Williams-Piehota PA; McCormack LA; Treiman K; Bann CM
    Health Educ Res; 2008 Jun; 23(3):440-53. PubMed ID: 18385197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Issues faced by unaffected men with a family history of prostate cancer: a multidisciplinary overview.
    Wakefield CE; Meiser B; Gaff CL; Barratt A; Patel MI; Suthers G; Lobb EA; Ramsay J; Mann GJ
    J Urol; 2008 Jul; 180(1):38-46; discussion 46. PubMed ID: 18485397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What will the emperor say? Screening for prostate cancer as of 2008.
    Concato J
    Cancer J; 2009; 15(1):7-12. PubMed ID: 19197166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening and management of prostate cancer in elderly men: the Iowa Prostate Cancer Consensus.
    Konety BR; Sharp VJ; Raut H; Williams RD
    Urology; 2008 Mar; 71(3):511-4. PubMed ID: 18342199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer screening, yes or no? The current controversy.
    Razi A
    Urol J; 2004; 1(4):240-5. PubMed ID: 17914698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shared decision making for prostate cancer screening: do patients or clinicians have a choice?
    Woolf SH; Krist A
    Arch Intern Med; 2009 Sep; 169(17):1557-9. PubMed ID: 19786673
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.